These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19088302)

  • 1. The effect of a chimeric human/murine anti-cocaine monoclonal antibody on cocaine self-administration in rats.
    Norman AB; Norman MK; Buesing WR; Tabet MR; Tsibulsky VL; Ball WJ
    J Pharmacol Exp Ther; 2009 Mar; 328(3):873-81. PubMed ID: 19088302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chimeric human/murine anticocaine monoclonal antibody inhibits the distribution of cocaine to the brain in mice.
    Norman AB; Tabet MR; Norman MK; Buesing WR; Pesce AJ; Ball WJ
    J Pharmacol Exp Ther; 2007 Jan; 320(1):145-53. PubMed ID: 17023573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a repeated dose of a recombinant humanized anti-cocaine monoclonal antibody on cocaine self-administration in rats.
    Wetzel HN; Tsibulsky VL; Norman AB
    Drug Alcohol Depend; 2016 Nov; 168():287-292. PubMed ID: 27736682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant humanized anti-cocaine monoclonal antibody inhibits the distribution of cocaine to the brain in rats.
    Norman AB; Gooden FC; Tabet MR; Ball WJ
    Drug Metab Dispos; 2014 Jul; 42(7):1125-31. PubMed ID: 24733787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a humanized recombinant anti-cocaine monoclonal antibody on the disposition of cocaethylene in mice.
    Wetzel HN; Tabet MR; Ball WJ; Norman AB
    Int Immunopharmacol; 2014 Dec; 23(2):387-90. PubMed ID: 25445957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the distribution of the cocaine priming threshold and the effect of SCH23390.
    Norman AB; Welge JA; Tsibulsky VL
    Brain Res; 2002 Aug; 946(2):253-61. PubMed ID: 12137929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular model for cocaine binding by the immunotherapeutic human/mouse chimeric monoclonal antibody 2E2.
    Lape M; Paula S; Ball WJ
    Eur J Med Chem; 2010 Jun; 45(6):2291-8. PubMed ID: 20185210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model.
    Kantak KM; Collins SL; Lipman EG; Bond J; Giovanoni K; Fox BS
    Psychopharmacology (Berl); 2000 Feb; 148(3):251-62. PubMed ID: 10755738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody.
    Paula S; Tabet MR; Farr CD; Norman AB; Ball WJ
    J Med Chem; 2004 Jan; 47(1):133-42. PubMed ID: 14695827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The self-administration of WIN 35,428 and cocaine: comparisons of satiety threshold and elimination half-life in rats.
    Norman AB; Buesing WR; Norman MK; Tabet MR; Tsibulsky VL
    Eur J Pharmacol; 2004 Jan; 483(2-3):281-7. PubMed ID: 14729118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priming threshold: a novel quantitative measure of the reinstatement of cocaine self-administration.
    Norman AB; Norman MK; Hall JF; Tsibulsky VL
    Brain Res; 1999 Jun; 831(1-2):165-74. PubMed ID: 10411996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine vaccines: antibody protection against relapse in a rat model.
    Carrera MR; Ashley JA; Zhou B; Wirsching P; Koob GF; Janda KD
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6202-6. PubMed ID: 10823960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the clinical efficacy and potential adverse effects of a humanized anticocaine monoclonal antibody.
    Norman AB; Ball WJ
    Immunotherapy; 2012 Mar; 4(3):335-43. PubMed ID: 22401638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats.
    Proksch JW; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):831-7. PubMed ID: 10688594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats.
    Baird TJ; Deng SX; Landry DW; Winger G; Woods JH
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1127-34. PubMed ID: 11082449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mathematical model of a recombinant humanized anti-cocaine monoclonal antibody's effects on cocaine pharmacokinetics in mice.
    Wetzel HN; Zhang T; Norman AB
    Life Sci; 2017 Sep; 184():81-86. PubMed ID: 28694087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The compulsion zone: a pharmacological theory of acquired cocaine self-administration.
    Norman AB; Tsibulsky VL
    Brain Res; 2006 Oct; 1116(1):143-52. PubMed ID: 16942754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats.
    Mantsch JR; Yuferov V; Mathieu-Kia AM; Ho A; Kreek MJ
    Psychopharmacology (Berl); 2004 Aug; 175(1):26-36. PubMed ID: 15042275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010.
    Kantak KM; Collins SL; Bond J; Fox BS
    Psychopharmacology (Berl); 2001 Jan; 153(3):334-40. PubMed ID: 11271406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Satiety threshold: a quantitative model of maintained cocaine self-administration.
    Tsibulsky VL; Norman AB
    Brain Res; 1999 Aug; 839(1):85-93. PubMed ID: 10482802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.